胞浆内单精子注射后3个原核和1个极体的人类合子的细胞遗传学分析

对体外受精-胚胎移植(IVF-ET)和胞浆内单精子注射(ICSI)后原核形成情况进行常规检查可以判定和分离异常受精的合子,德国Rosenbusch等对ICSI后显示3个原核和1个极体的人类合子进行了细胞遗传学分析,试图阐明妊娠最早期染色体异常的频率与起源。

买卖人类配子、合子和胚胎行为的刑法规制

为非法应用人类辅助生殖技术而实施的买卖人类配子、合子和胚胎及其衍生行为,直接违反了我国行政法规的相关规定,具备行政违法性。同时,会对国家、对人类辅助生殖技术管理秩序法益、人格尊严法益、公民身体健康法益和公共卫生法益造成侵害,具备刑事违法性。买卖人类配子、合子和胚胎的行为的本质是行政犯,出于行刑衔接和保护法益的需要,应当对买卖人类配子、合子和胚胎的行为进行刑法规制。买卖人类配子、合子和胚胎的行为情节严重的,应当承担相应刑事责任。

Study on the expression and mutation of human telomeric repeat binding factor (hTRF1) in 10 malignant hematopoietic cell lines

Objective： Detecting the expression and mutation of human telomeric repeat binding factor （hTRF1） in 10 malignant hematopoietic cell line cells on the base of determining its genomic structure and its four pseudogenes to clarify ifhTRF1 mutation is one of the factors of the activation of telomerase. Methods： hTRFlcDNA sequences were obtained from GenBank, its genome structure and pseudogenes were forecasted by BLAST and other biology information programs and then testified by sequencing. Real-time RT-PCR was used to detect the expression of h TRFlmRNA in 10 cell line cells, including myelogenous leukemia cell lines K562, HL-60, U-937, NB4, THP-I, HEL and Dami; lymphoblastic leukemia cell lines 6T-CEM, Jurkat and Raji. Telomerase activities of cells were detected by using telomeric repeat amplification （TRAP）-ELISA protocol. PCR and sequencing were used to detect mutation of each exon ofhTRF1 in 10 cell line cells. Results： hTRF1 gene, mapped to 8q13, was divided into 10 exons and spans 38.6 kb. Four processed pseudogenes ofhTRF1 located on chromosome 13, 18, 21 and X respectively, was named as ψhTRFI-13, ψhTRFI-18, ψhTRF1-21 and ψhTRFI-X respectively. All cell line cells showed positive telomerase activity. The expression of hTRF1 was significantly lower in malignant hematopoietic cell lines cells （0.0338, 0.0108-0.0749） than in normal mononuclear cells （0.0493, 0.0369-0.128） （P=0.004）. But no significant mutation was found in all exons of hTRF1 in 10 cell line cells. Four variants were found in part ofintron 1, 2 and 8 ofhTRF1. Their infection on gene function is unknown and needs further studies. Conclusion： hTRF1 mutation is probably not one of the main factors for telomerase activation in malignant hematopoietic disease.

Prediction of HLA-A 2.1-restricted CTL epitopes from IGFBP7 antigen of lung carcinoma

Objective： With the development of peptide-based cancer specific immunotherapy, the prediction of CTL epitopes from insulin-like growth factor-binding protein 7 （IGFBP7） is very important for some research about tumor metastasis. Because HLA-A2.1-expressing individuals cover 〉50% in the population of China, we aimed at identifying IGFBPT-encoded peptide presented by HLA-A2.1. Methods： In our study, a HLA-A2.1 restricted CTL epitope was identified by using the following two-step procedure： （a） computer-based epitope prediction from the amino acid sequence of IGFBP7 antigen; （b） Validation with epitope molecular modeling. Results： We obtained four epitopes with high immunogenicity scores by all of the three algorithms, i.e., BIMAS, SYFPEITH1 and IMTECH. Each of the four candidates satisfied the criteria of the HLA-A2.1- restricted CTL epitopes in molecular modeling analysis. Conclusion： The combination of BIMAS, SYFPEITHI and IMTECH method can improve the prediction efficiency and accuracy. Due to this research herein, this four epitopes have potential value for further studied, also have potential application in peptide-mediated immunotherapy. These epitopes may be useful in the design of therapeutic peptide vaccine for lung carcinoma and as immunotherapeutic strategies against lung carcinoma after identified by immunology experiment.

A molecular dynamics and computational study of human KAT3 involved in KYN pathway

Kynurenine aminotransferases （KATs） catalyze the transamination of kynurenine （KYN） pathway and endogenous KYNs have been suggested to highly correlate to abnormal brain diseases. HKAT3 is a key member of KAT family, while the binding mechanism of KYN and cofactor with HKAT3 has not been determined yet. In this study, we focus on the structure-function relationship among KYN, cofactor and HKAT3. The binding models of KYN complex and KYN＆cofactor complex were ob- tained and were studied by molecular dynamics （MD） simulations. We identified several critical residues and influence of conformational changes in human kynurenine aminotransferase 3 （HKAT3） complexes. The cofactor may contribute largely not only to the catalysis, but also to the binding. In addition, a hypothesis is proposed that a strong hydrophobic interaction between Tyr159 and Lys280 may influence the binding mode and the binding region of the substrate and the cofactor. Our re- suits will be a good starting point for further determination of the biological role.

A Novel Approach to Construct a Composite Indicator by Maximizing Its Sum of Squared Correlations with Sub-Indicators

In the paper, a novel practical approach to construct a composite indicator （CI） is pro- posed. The key idea is to decide the weights of sub-indicators in constructing a composite indicator by maximizing the sum of squared correlations between the CI and sub-indicators. The CI obtained in this fashion has the maximum sum of squared correlations among all linear estimators. In addition, the simple, exact and explicit solutions of weights are proposed under the condition of non-negative irreducible matrix. Moreover, under this particular condition, the proposed method will become the principal component analysis. For illustration purpose, the proposed novel approach is utilized to cal- culate Sustainable Energy Index and Human Development Index which are two often-used cases to compare models in the literatures. The results the methods of Hatefi, et al. （2010） and Zhou all sub-indicators＇ correlations. show that the power of the proposed method outweigh et al. （2007） in terms of the sum of absolute values of